English:US Search You are here: Home » Products » For the Neurosurgeon » Duraplasty » Suturable DuraGen® matrix For the Burn and Wound Surgeon For the Extremity Reconstruction Surgeon For the Liver Surgeon For the Neurosurgeon Brain Mapping Cranial Stabilization CSF Management Duraplasty DuraGen Plus™ Adhesion Barrier Matrix DuraGen® Plus matrix DuraGen® Secure matrix DuraSeal® Cranial Sealant System DuraSeal® Xact Spinal Sealant System Suturable DuraGen® matrix Electrosurgery NeuroCritical Care Stereotaxy Tissue Ablation Instruments Surgical Instruments Customer Portal Integra News Integra Events Transparence Loi Bertrand Professionnels de santé exerçant en France, veuillez consulter la page Bienvenue. Suturable DuraGen® matrix Limit uncertainty with the resistance to suturing offered by Suturable DuraGen® matrix. As one of the pioneers in regenerative collagen medicine and thanks to its Ultra Pure Collagen™ technology, Integra proposes Duraplasty Solution™ for natural dural regeneration and CSF leakages prevention. Features Bilayer matrix: Suturable DuraGen® matrix combines the conformability of DuraGen® Plus matrix in addition to its suturability. Enhanced graft strength: Suturable DuraGen® matrix features an enhanced strength component (NeuraGen®) providing the graft the possibility of mechanical anchoring for challenging procedures. Indications Suturable DuraGen® is indicated as a dural substitute for the repair and restoration of dural defects in cranial and spinal surgical procedures. Suturable DuraGen® readily conforms to the surface of the brain and overlying tissues. Suturable DuraGen® may be used to close dural defects following traumatic injury, excision, retraction or shrinkage. Suturable DuraGen® may be used to supplement primary closure. Suturable DuraGen® may be used in the following procedures: Cranial Convexity: may be used to cover large defects following surgery, especially for dural loss from excision, contraction, retraction and/or shrinkage; Brain Swelling: intra-operative brain swelling or anticipated postoperative swelling; Posterior Fossa Surgery: 1) General use as a dural graft, 2) decompression craniectomy and dural release for infarcts, i.e., Posterior Inferior Cerebellar Artery (PICA) infarcts, 3) anticipated swelling after trauma, and 4) may be used in Chiari decompression procedures; Spinal Surgery: 1) General use as a spinal dural graft, especially useful for defects arising from pinhole tears, disc surgery, and spinal stenosis decompression, 2) after resection of intradural tumors, 3) Onlay graft after dural approximation with sutures, and 4) as a separation layer between the dura and overlying tissues. Contraindications Suturable DuraGen® is not designed, sold or intended for use except as described in the indications for use and is contraindicated in the following situations: For patients with a known history of hypersensitivity to bovine derived materials. Should be used with caution in infected regions. Ordering Information Reference Description Quantity DURS1391ITL 1x3in - 2.5x7.5cm box/1 DURS1395ITL 1x3in - 2.5x7.5cm box/5 DURS2291ITL 2x2in - 5x5cm box/1 DURS2295ITL 2x2in - 5x5cm box/5 DURS3391ITL 3x3in - 7.5x7.5cm box/1 DURS3395ITL 3x3in - 7.5x7.5cm box/5 DURS4591ITL 4x5in - 10x12.5cm box/1 Product Catalogues – Regulatory Information Class III Integra LifeSciences Corporation 311 Enterprise Drive Plainsboro, NJ 08536 • USA Integra LifeSciences Services (France) SAS Immeuble Sequoia 2 • 97 allée Alexandre Borodine Parc technologique de la Porte des Alpes 69800 Saint Priest • FRANCE Phone: +33 (0)4 37 47 59 00 • fax: +33 (0)4 37 47 59 99 emea.info@integralife.com integralife.eu Legal information Availability of these products might vary from a given country or region to another, as a result of specific local regulatory approval or clearance requirements for sale in such country or region. • Please read carefully the instructions for use. • Non contractual document. Integra reserves the right, without prior notice, to modify the products in order to improve their quality. • Warning: Applicable laws restrict these products to sale by or on the order of a physician. Additional information for EMEA Customers only: Products mentioned in this document are CE class III devices. Please contact Integra customer service should you need any additional information on devices classification. All the medical devices mentioned on this document are CE marked according to European council directive 93/42/ EEC on medical devices and its relatives, unless specifically identified as “NOT CE MARKED”. DuraGen is a registered trademark of Integra Lifesciences Corporation in the United States and/or other countries. Ultra Pure Collagen is a trademark of Integra LifeSciences Corporation or its subsidiaries in the United States and/or other countries. All rights reserved. Last modifcation date: 05/2016. 0472247-1-EN Document for use in Europe, Middle-East & Africa only. For more information, please contact your Integra representative. For complete product information, please consult product labels and inserts for any indications, contraindications, hazards, warnings, precautions, and instructions for use. Message for healthcare professionals working in France only / Message à destination des professionnels de santé exerçant en France: Ce site n'est pas en accord avec la loi Bertrand; les pages produits ne vous sont pas adressées. Pour tout renseignement sur la société Integra et la loi Bertrand, veuillez consulter la page bienvenue. © Copyright 2010-2018 Integra LifeSciences Corporation. All rights reserved. | Terms of use | Privacy policy | Sitemap integralife.eu cookie policy We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. Accept Cookies Cookie Settings